Literature DB >> 20042058

Zoonotic infections of buffalopox in India.

V Bhanuprakash1, G Venkatesan, V Balamurugan, M Hosamani, R Yogisharadhya, P Gandhale, K V Reddy, A S Damle, H N Kher, B S Chandel, H C Chauhan, R K Singh.   

Abstract

Four outbreaks of buffalopox in domestic buffaloes, with considerable mortality with high case fatality rates in young buffalo calves and high morbidity with significant productivity loss in terms of reduction in milk yield in adult animals along with severe zoonotic infection in milk attendants were recorded at various places in India, during 2006-2008. In buffaloes, the pox lesions were confined to udder and teats of the majority of the affected animals, and in few animals the lesions were appeared on the hindquarters, indicating generalized infection. The overall disease morbidity, mortality and case fatality rate were 6.8%, 0.7% and 11.4% respectively. Milkers developed pox-like lesions on the hands, forearms and forehead accompanied by fever, axillary lymphadenopathy and general malaise. The causative agent of the outbreaks, buffalopox virus (BPXV), was confirmed upon virus isolation in cell culture, electron microscopy, A-type inclusion (ATI) and ankyrin repeat protein (C18L) gene-specific polymerase chain reactions (PCR). Further, sequence analysis of the BPXV isolates from human and buffalo showed more identity of ATI and C18L genes sequences with that of other orthopoxviruses at nucleotide and amino acid levels and confirmed a close relationship of BPXV with Vaccinia virus (VACV) or VACV-like viruses. Considering the zoonotic impact and productivity losses of buffalopox infection, the control measures are imperative in curtailing economic and public health impact of the disease.
© 2009 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20042058     DOI: 10.1111/j.1863-2378.2009.01314.x

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  27 in total

1.  Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.

Authors:  Sophie Duraffour; Graciela Andrei; Dimitri Topalis; Marcela Krečmerová; Jean-Marc Crance; Daniel Garin; Robert Snoeck
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  KAY-2-41, a novel nucleoside analogue inhibitor of orthopoxviruses in vitro and in vivo.

Authors:  Sophie Duraffour; Robert Drillien; Kazuhiro Haraguchi; Jan Balzarini; Dimitri Topalis; Joost J van den Oord; Graciela Andrei; Robert Snoeck
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

3.  Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques.

Authors:  Graham J Hatch; Victoria A Graham; Kevin R Bewley; Julia A Tree; Mike Dennis; Irene Taylor; Simon G P Funnell; Simon R Bate; Kimberley Steeds; Thomas Tipton; Thomas Bean; Laura Hudson; Deborah J Atkinson; Gemma McLuckie; Melanie Charlwood; Allen D G Roberts; Julia Vipond
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

4.  Genomic analysis of the vaccinia virus strain variants found in Dryvax vaccine.

Authors:  Li Qin; Chris Upton; Bart Hazes; David H Evans
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

5.  Evolution of and evolutionary relationships between extant vaccinia virus strains.

Authors:  Li Qin; Nicole Favis; Jakub Famulski; David H Evans
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

6.  Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.

Authors:  Jitendra Kumar; Viveka Nand Yadav; Swastik Phulera; Ashish Kamble; Avneesh Kumar Gautam; Hemendra Singh Panwar; Arvind Sahu
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 7.  Humans and cattle: a review of bovine zoonoses.

Authors:  Clinton J McDaniel; Diana M Cardwell; Robert B Moeller; Gregory C Gray
Journal:  Vector Borne Zoonotic Dis       Date:  2013-12-17       Impact factor: 2.133

8.  Emergence and reemergence of vaccinia-like viruses: global scenario and perspectives.

Authors:  R K Singh; V Balamurugan; V Bhanuprakash; G Venkatesan; M Hosamani
Journal:  Indian J Virol       Date:  2012-04-04

9.  Serologic evidence of orthopoxvirus infection in buffaloes, Brazil.

Authors:  Felipe Lopes de Assis; Graziele Pereira; Cairo Oliveira; Gisele Olinto Libânio Rodrigues; Marcela Menezas Gomes Cotta; Andre Tavares Silva-Fernandes; Paulo Cesar Peregrino Ferreira; Cláudio Antônio Bonjardim; Giliane de Souza Trindade; Erna Geessien Kroon; Jônatas Santos Abrahão
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

10.  Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates.

Authors:  Joseph W Golden; Matthew Josleyn; Eric M Mucker; Chien-Fu Hung; Peter T Loudon; T C Wu; Jay W Hooper
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.